(Q38049472)

27 August 2017

title

Evolution of axillary nodal staging in breast cancer: clinical implications of the ACOSOG Z0011 trial (English)

1 reference

27 August 2017

1 reference

2

Judy C Boughey

1 reference

27 August 2017

Miraj Shah-Khan

1

1 reference

27 August 2017

language of work or name

1 reference

1 October 2012

1 reference

27 August 2017

1 reference

27 August 2017

volume

19

1 reference

27 August 2017

issue

4

1 reference

27 August 2017

page(s)

267-276

1 reference

I. The Results of Radical Operations for the Cure of Carcinoma of the Breast

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F107327481201900403

Comparison of radical mastectomy with alternative treatments for primary breast cancer:A first report of results from a prospective randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481201900403

Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481201900403

Learning sentinel node biopsy: results of a prospective randomized trial of two techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481201900403

Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481201900403

Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481201900403

Axillary recurrence after a negative sentinel node biopsy for breast cancer: incidence and clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481201900403

American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481201900403

NCCN clinical practice guidelines in oncology: breast cancer screening and diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481201900403

Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a metaanalysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481201900403

Sentinel lymph-node biopsy-based prediction of further breast cancer metastases in the axilla

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481201900403

Non-sentinel lymph node metastases associated with isolated breast cancer cells in the sentinel node

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481201900403

A declining rate of completion axillary dissection in sentinel lymph node-positive breast cancer patients is associated with the use of a multivariate nomogram.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481201900403

Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481201900403

Observation of the breast cancer patient with a tumor-positive sentinel node: implications of the ACOSOG Z0011 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481201900403

The new era in breast cancer. Invasion, size, and nodal involvement dramatically decreasing as a result of mammographic screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481201900403

Association of occult metastases in sentinel lymph nodes and bone marrow with survival among women with early-stage invasive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481201900403

Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481201900403

Trends in and outcomes from sentinel lymph node biopsy (SLNB) alone vs. SLNB with axillary lymph node dissection for node-positive breast cancer patients: experience from the SEER database

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481201900403

Validation of a breast cancer nomogram for predicting nonsentinel lymph node metastases after a positive sentinel node biopsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481201900403

Incorporation of sentinel lymph node metastasis size into a nomogram predicting nonsentinel lymph node involvement in breast cancer patients with a positive sentinel lymph node

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481201900403

New models and online calculator for predicting non-sentinel lymph node status in sentinel lymph node positive breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481201900403

The impact of age on outcome in early-stage breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481201900403

Local recurrence after breast-conserving surgery: multivariable analysis of risk factors and the impact of young age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481201900403

A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481201900403

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481201900403

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481201900403

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481201900403

Multidisciplinary considerations in the implementation of the findings from the American College of Surgeons Oncology Group (ACOSOG) Z0011 study: a practice-changing trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481201900403

Basal breast cancer molecular subtype predicts for lower incidence of axillary lymph node metastases in primary breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481201900403

Lymphovascular invasion and lobular histology are associated with increased incidence of isolated tumor cells in sentinel lymph nodes from early-stage breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481201900403

Axillary dissection versus no axillary dissection in elderly patients with breast cancer and no palpable axillary nodes: results after 15 years of follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481201900403

Role of axillary clearance after a tumor-positive sentinel node in the administration of adjuvant therapy in early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481201900403

10.1177/107327481201900403

21 January 2018

Identifiers

DOI

0 references

1 reference